GLOW Peptide Canada: What Is in the 70mg Blend and How to Check It
A single-compound vial comes with one identity and one purity figure. A blend does not, and that changes how a lab should specify it, receive it and file its paperwork. This guide looks at GLOW peptide in Canada from the point of view of research teams buying in volume: what the three components are, how the label weight splits by mass and by molecule count, why one purity number cannot describe the mixture, and what to check when a multi-vial GLOW order reaches your receiving bench.
What the 70 in GLOW 70mg adds up to
The figure in the product name is the combined peptide content of the vial. It is not the amount of any single component. GLOW is built from three compounds:
| Component | Amount per vial | Sequence or form | Formula | Approx. mass |
|---|---|---|---|---|
| BPC-157 | 10 mg | 15-residue linear peptide (GEPPPGKPADDAGLV) | C62H98N16O22 | 1419.5 g/mol |
| TB-500 | 10 mg | Acetylated LKKTETQ, a 7-residue fragment of thymosin beta-4 | C38H68N10O14 | 889.0 g/mol |
| GHK-Cu | 50 mg | Gly-His-Lys tripeptide bound to copper(II) | C14H23CuN6O4 | 402.9 g/mol |
Ten plus ten plus fifty gives the 70. Its sibling, KLOW 80mg, contains the identical trio with 10 mg of KPV (Lys-Pro-Val) added, so the only chemical difference between the two products is that one extra tripeptide.
Two naming points are worth writing into your specification. TB-500 is a short synthetic fragment, not the full 43-residue thymosin beta-4 protein, and the two should never share a line in an inventory system. GHK-Cu is a metal complex, so its mass depends on whether a figure is quoted for the complex or for the bare tripeptide.
Mass ratio versus molar ratio
By weight, GLOW is split 1:1:5, which already tells you that most of the vial is copper tripeptide. The imbalance grows once you count molecules instead of milligrams, because GHK-Cu is by far the smallest component. Working from the masses in the table, and treating the 50 mg as the copper complex:
- BPC-157: about 7.0 micromoles per vial
- TB-500: about 11.2 micromoles per vial
- GHK-Cu: about 124 micromoles per vial
That works out to roughly 1 : 1.6 : 17.6 on a molar basis. For anyone designing in-vitro experiments around a blend, or comparing it with single-compound controls, the molar figure is usually the more meaningful one. It also explains a visual quirk: the lyophilised cake and any analytical solution made from it take on the blue tint of the copper complex, even though two of the three components are colourless.
Why one purity number cannot describe a blend
For a single peptide, HPLC purity answers a clear question: what share of the peptide material is the intended sequence. In a three-component vial there are three intended sequences, so a lone percentage has no clean meaning. Several practical issues follow:
- UV response is not proportional to mass. At the low wavelengths used for peptides, absorbance depends on the peptide bonds and side chains present. Peak areas from different compounds cannot be read as their mass shares without a reference standard for each.
- Each component needs its own peak. A 15-mer, an acetylated 7-mer and a copper-bound tripeptide differ enough in size and hydrophobicity that a sound reversed-phase method should resolve them. A report that shows one main peak for the whole blend should raise questions.
- Quality is best settled before blending. The most reliable assurance comes from characterising each component as a separate lot before it is combined. Testing the finished mixture confirms what is present, but it is a harder chromatogram to interpret than three single-compound traces.
When you read a blend report, look for component identification by retention and by mass, and for per-component figures where the lab provides them.
The copper component needs its own test
GHK-Cu raises a separate question from the other two peptides. HPLC purity describes the peptide portion, and under the acidic mobile phases common in peptide chromatography the copper complex may not stay intact on the column. Whether the tripeptide actually carries its expected copper load is a different measurement, typically an elemental or colourimetric copper determination. A document that covers peptide purity but says nothing about copper has characterised only part of the vial.
Receiving GLOW peptide in Canada: a multi-vial checklist
A larger order of blend vials is easiest to manage when the receiving routine is written down and followed the same way every time. A practical sequence:
- Check each vial label against the purchase order and confirm GLOW has not been mixed with KLOW, which looks identical at a glance.
- Group vials by cap and crimp colour. Vials are matched to their certificate by those colours, so the grouping tells you which document applies.
- Pull the matching certificate from the certificates of analysis page where one is posted, and file it against those vials. Certificates are published for some products rather than every one; if yours is not listed, ask support for what is on file.
- Record vial count, arrival date and the condition of the cake. A blue, intact cake is expected.
- Move stock into cold, dark storage on the day of arrival and note the storage location in your inventory log.
Keeping a whole order to a single lot, where you can, simplifies the log considerably. One lot means one set of component ratios and one reference document for every vial on the shelf.
Blend or separate vials for a volume order
The defining trade-off with any pre-mixed product is that the ratio is fixed at manufacture. Nothing done later in the lab changes the 1:1:5 split. If your work needs the ratio as a variable, or needs single-compound controls alongside the mixture, separate vials of BPC-157, TB-500 and GHK-Cu are the only way to get that control.
If the fixed ratio suits your design, the GLOW 70mg vial reduces three inventory lines, three lots and three documents to one of each, which is a genuine saving for a team tracking hundreds of vials. Because volume pricing at Bulk Peptides is mix-and-match, every vial in the cart counts toward the break, so a combined order of blends and single compounds is priced on its total vial count. Both GLOW and KLOW sit in the multi-peptide blends range, and products are third-party tested for purity by HPLC.
GLOW, KLOW and their components are supplied strictly for in-vitro laboratory research. Health Canada has not authorised any of them as a drug or natural health product, they must not be used in people or animals, and this article offers no guidance on use.
Choosing between the two blends for a volume order? See GLOW vs KLOW in bulk.
